Search

everythinglearnresearchcommunity

for

Search:↓

Immune checkpoint inhibitors can increase the risk of autoimmune skin diseases, especially bullous pemphigoid.

Methylated flavonoids may effectively reduce depression and inflammation caused by finasteride.

FAPD and possibly CCCA may be AGA subtypes, and treatments combining antiandrogens, hair growth agents, hair transplants, and anti-inflammatories could be effective.

Genetics can help tailor treatments for male pattern hair loss, improving outcomes like stabilization or modest regrowth.

Plakophilin 1 helps control skin cell immune responses to prevent excessive inflammation.

Tyrosine kinase inhibitors for endocrine tumors often cause skin issues, requiring early management and treatment adjustments.

Psoriasis patients are more likely to develop alopecia areata due to complex autoimmune interactions.

New targeted therapies for psoriasis show promise but face challenges like side effects and treatment resistance.

Janus Kinase inhibitors are effective and safe for treating alopecia areata, but more research is needed.

De nouvelles thérapies promettent de mieux traiter la perte de cheveux due à l'alopécie androgénétique.

Acne is linked to inflammation and insulin resistance, and is associated with various syndromes that require different treatments.

ePUKs could be valuable for regenerative medicine due to their wound healing abilities.

Grape seed extract is good for skin care, with antioxidant, anti-inflammatory, and anti-cancer effects.

2011 dermatology discussions highlighted stem cell hair treatments, new lichen planopilaris therapies, skin side effects from cancer drugs, emerging allergens, and the link between food allergies and skin issues.

Hair follicles can be used to quickly assess drug effects in cancer treatment.

Research on hair disorders has advanced, with promising future progress in understanding and treating these conditions.

Some cancer and immune system drugs can cause serious side effects, including heart, lung, nerve, and organ damage, which need careful monitoring and management.

The patient with total hair loss did not regrow hair despite treatment, indicating a poor outlook for this type of hair loss.

Active oxygen scavengers can reverse the suppression of hair cell growth caused by androgens.

Dihydrotestosterone increases growth and spread of human brain cancer cells, and blocking its formation might help treat this cancer.

Hair follicle development is controlled by interactions between skin tissues and specific molecular signals.

No effective treatment for frontal fibrosing alopecia was found, but oral 5-alpha-reductase inhibitors had the best response; for lichen planopilaris, topical corticosteroids were commonly used but had a high relapse rate.

5α-reductase inhibitors may cause persistent sexual dysfunction and depression, needing more research on long-term effects.

FGF signaling is a promising target for developing treatments for wounds, metabolic diseases, and cancer.

Hormones and metabolism play a complex role in prostate enlargement, and more research is needed to improve diagnosis and treatment.

Finasteride increases hair density in female androgenetic alopecia, but individual results may vary.

Natural 5α-reduced glucocorticoids might be anti-inflammatory with fewer side effects than current options.

Some hormone-related drugs may protect brain cells in Parkinson's disease differently in men and women.

Cellular senescence has both cancer-blocking and cancer-promoting effects, and targeting senescent cells may improve health and lifespan.

M50054 may help treat hepatitis and hair loss from chemotherapy.